$82.18
-2.86-3.36%
In chiusura: Sep 11, 5:00 PM EST
$81.05
-1.13-1.38%
Post-mercato: 5:45 PM EST

TransMedics Group (TMDX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
TransMedics Group (TMDX) ha pubblicato l'ultima guidance il settembre 10, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $737M - $757M per il periodo.
Rispetto alle previsioni precedenti, TransMedics Group ha modificato le sue previsioni di fatturato da un intervallo precedente di .
TransMedics Group ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il TransMedics Group. 18
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.52 | $0.61 | $0.39 | $0.36 |
| Actual | $0.44 | $0.30 | $0.57 | $0.66 |
| Surprise | -15.4% | -50.8% | +46.2% | +83.3% |
| Revenue | ||||
| Estimate | $184.1M | $174.4M | $155.3M | $144.8M |
| Actual | $189.9M | $173.9M | $160.8M | $143.8M |
| Surprise | +3.20% | -0.26% | +3.50% | -0.69% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.29 | $0.49 | $0.55 | $0.63 |
| Revenue | ||||
| Consensus | $177.6M | $201.0M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $0.44 | $0.52 | -15.4 % |
| Q1 | May 5, 2026 | $0.30 | $0.61 | -50.8 % |
| Q4 | Feb 24, 2026 | $0.57 | $0.39 | 46.2 % |
| Q3 | Oct 29, 2025 | $0.66 | $0.36 | 83.3 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $189.95M | $184.06M | 3.20 % |
| Q1 | May 5, 2026 | $173.93M | $174.38M | -0.26 % |
| Q4 | Feb 24, 2026 | $160.76M | $155.33M | 3.50 % |
| Q3 | Oct 29, 2025 | $143.82M | $144.83M | -0.69 % |